Preventive treatment in migraine and the new US guidelines

E Estemalik, S TepperCleveland Clinic, Neurological Center for Pain, Cleveland, Ohio, USAAbstract: Migraine headaches are among the most common headache disorders seen in various practices. The prevalence of migraine headaches is 18% in women and 6% in men. While millions of Americans suffer from mi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Estemalik E, Tepper S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/2c614fcd2f9745c88d3f06943c544356
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:2c614fcd2f9745c88d3f06943c544356
record_format	dspace
spelling	oai:doaj.org-article:2c614fcd2f9745c88d3f06943c5443562021-12-02T05:07:13ZPreventive treatment in migraine and the new US guidelines1176-63281178-2021https://doaj.org/article/2c614fcd2f9745c88d3f06943c5443562013-05-01T00:00:00Zhttp://www.dovepress.com/preventive-treatment-in-migraine-and-the-new-us-guidelines-a13084https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021E Estemalik, S TepperCleveland Clinic, Neurological Center for Pain, Cleveland, Ohio, USAAbstract: Migraine headaches are among the most common headache disorders seen in various practices. The prevalence of migraine headaches is 18% in women and 6% in men. While millions of Americans suffer from migraine headaches, roughly 3%–13% of identified migraine patients are on preventive therapy, while an estimated 38% actually need a preventive agent. The challenge among physicians is not only when to start a daily preventive agent but which preventive agent to choose. Circumstances warranting prevention have been described in the past, and in 2012, a new set of guidelines with an evidence review on preventive medications was published. A second set of guidelines provided evidence on nonsteroidal anti-inflammatory drugs, herbs, minerals, and vitamins for prevention of episodic migraine. This article describes the updated US guidelines for the prevention of migraines and also outlines the major studies from which these guidelines were derived.Keywords: US guidelines, Canadian guidelines, classification, preventive medicationEstemalik ETepper SDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 709-720 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Estemalik E Tepper S Preventive treatment in migraine and the new US guidelines
description	E Estemalik, S TepperCleveland Clinic, Neurological Center for Pain, Cleveland, Ohio, USAAbstract: Migraine headaches are among the most common headache disorders seen in various practices. The prevalence of migraine headaches is 18% in women and 6% in men. While millions of Americans suffer from migraine headaches, roughly 3%–13% of identified migraine patients are on preventive therapy, while an estimated 38% actually need a preventive agent. The challenge among physicians is not only when to start a daily preventive agent but which preventive agent to choose. Circumstances warranting prevention have been described in the past, and in 2012, a new set of guidelines with an evidence review on preventive medications was published. A second set of guidelines provided evidence on nonsteroidal anti-inflammatory drugs, herbs, minerals, and vitamins for prevention of episodic migraine. This article describes the updated US guidelines for the prevention of migraines and also outlines the major studies from which these guidelines were derived.Keywords: US guidelines, Canadian guidelines, classification, preventive medication
format	article
author	Estemalik E Tepper S
author_facet	Estemalik E Tepper S
author_sort	Estemalik E
title	Preventive treatment in migraine and the new US guidelines
title_short	Preventive treatment in migraine and the new US guidelines
title_full	Preventive treatment in migraine and the new US guidelines
title_fullStr	Preventive treatment in migraine and the new US guidelines
title_full_unstemmed	Preventive treatment in migraine and the new US guidelines
title_sort	preventive treatment in migraine and the new us guidelines
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/2c614fcd2f9745c88d3f06943c544356
work_keys_str_mv	AT estemalike preventivetreatmentinmigraineandthenewusguidelines AT teppers preventivetreatmentinmigraineandthenewusguidelines
_version_	1718400580663115776

Preventive treatment in migraine and the new US guidelines

Ejemplares similares